The U.S. Food and Drug Administration (FDA) has approved Movantik (naloxegol) tablets drugs that are used for the treatment of constipation, Nektar Therapeutics (NASDAQ:NKTR) has said. In the statement, the pharmaceuticals company announced that the drug has successfully gone through the agency’s approval intricacies to attain their approval as a treatment of constipation caused by…